Trim 20-25% of BRK-B at $516; CPI catalyst and mean-reversion setup warrant reduced exposure
The prior Hold decision at $529 (Aug 10) explicitly identified the same mean-reversion setup but failed to trim exposure, producing -2.5% raw return and -2.1% alpha. All three analysts converge on technical facts: Aug-11 distribution candle on 4.63M shares (above 30-day avg), RSI bearish divergence at 52-week high, decelerating MACD histogram, upper Bollinger Band rejection at $532.94. Forward P/E of 23.65x is a premium to S&P ~22x for a low-growth conglomerate, with 45% TTM-to-Forward EPS normalization already priced in. The binary CPI catalyst ahead creates hot-print risk that could compress the $685B equity portfolio via higher discount rates and trigger a 2-3% single-day drop. The $4.5B buyback (0.4% of $1.1T market cap) is qualitatively meaningful but mathematically insufficient to override near-term risk. The neutral analyst's 15-20% trim with contingent reload is the right zone; splitting toward upper end (20-25%) because the prior lesson specifically warned against underacting on this setup. The $487 stop gives room for normal volatility — ATR is $8.46 and recent daily ranges are $13, so a $497 stop would whipsaw on routine mean-reversion. This is a timing/valuation call, not a thesis rejection; structural quality (0.607 beta, $365B cash, resumed buybacks, Abel track record) remains intact.
| Position | Action |
|---|---|
| Current exposure level | Trim 20-25% of BRK-B at $516 |
| Remaining position after trim | Hard stop at $487 (below 200 SMA at $491) |
| Trimmed proceeds | Deploy to reserve cash; defer reload until post-CPI print |
Berkshire Hathaway offers an asymmetric risk/reward opportunity with $365.5B in deployable capital, a confirmed uptrend, and a $4.5B buyback signal that management considers their own stock cheap — making any pullback to $500-505 a buying opportunity.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $516.57 | neutral |
| 50 SMA | $496.95 | bullish |
| 200 SMA | $491.35 | bullish |
| RSI (14) | 58.58 | neutral |
| MACD | +7.89 | bullish |
| MACD Signal | +6.28 | bullish |
| MACD Histogram | +1.61 | bullish |
| Bollinger Middle (20 SMA) | $505.49 | neutral |
| Bollinger Upper Band | $532.94 | bearish |
| Bollinger Lower Band | $478.04 | neutral |
| ATR (14) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price reaches $491-$497
Then: Higher-conviction reload band
Greg Abel's $4.5B buyback is the ultimate insider signal that BRK-B is undervalued
↩ rebuts: “Bear's reliance on Michael Burry's 'capital discipline breaking under Abel' thesis”
EV: +530+ · concedes: Forward P/E of 23.65x is not a screaming buy — but comparing to normalized earnings, it's reasonable for a quality compounder; Yes, there is risk of a pullback — but 3-5% drawdowns from a 52-week high are normal for BRK-B; Currency swings are real — but they're transitory and don't change underlying earning power; Burry was right once about housing — but his post-2008 track record is mixed; Succession risk is a real concern for some investors — though the market is actively voting otherwise with the stock at 52-week highs
The bull case conflates Berkshire's quality with timing, ignoring that $516 is a poor entry after a distribution candle at 52-week highs, a premium forward P/E relative to the S&P 500, non-recurring Q2 earnings, and unproven capital allocation under Abel in a market stress scenario.
EV: -3 to -5% (retest of 50 SMA at $497) · concedes: Long-term trend is not broken; Underlying businesses are solid; Buyback is not definitively bearish; The market is giving Abel the benefit of the doubt for now; If BRK-B holds $497 on volume, then there is a higher-conviction long setup
→ vs conservative: Fortress balance sheet thesis is '20-year-old thesis'—defensive compounds go down 15-25% in bear markets, just slower; 0.4% buyback is token gesture, not signal of undervaluation; paying premium P/E for no-growth conglomerate with negative real yield on $365B cash pile
→ vs neutral: Waiting for $500-$505 pullback risks missing 5-8% upside if stock grinds to $530-$540 on soft CPI; neutral analyst implicitly assumes pullback is coming but protects against 2% downside while accepting opportunity cost of missing larger move
| $8.46 |
| neutral |
| VWMA (20) | $512.31 | neutral |
Support: 478.04 · 491.35 · 496.95 · 505.49 · 512.31 · 516.57 | Resistance: 516.38 · 525 · 529 · 529.42 · 532.94
BRK-B is in a mature, stretched rally phase with near-term topping behavior (bearish intraday reversal Aug-11, RSI divergence, Bollinger upper-band contact at $532.94) but a still-intact underlying uptrend. The bullish stack (10 EMA > 50 SMA > 200 SMA) remains valid. Recommended actions: HOLD for existing positions with trailing stop at $505, WAIT for new entries on pullback to $500-505 (3.7% pullback) or $491-497 (5% pullback). Short-term risk of additional 2-4% pullback is meaningful; full trend break risk is low until/unless $497 closes below on volume. ATR of $8.46 should be used for stop-loss sizing.
Market Cap
$1,105.4B
Beta (5Y)
0.607
52-Week High
$537.74
52-Week Low
$464.01
50-Day Avg Price
$496.11
200-Day Avg Price
$491.23
P/E (TTM)
12.99x
Forward P/E
23.65x
PEG Ratio
10.06
EPS (TTM)
$39.76
Forward EPS
$21.82
Price to Book
0.001 (data anomaly)
Revenue (TTM)
$384.7B
Gross Profit
$116.7B
EBITDA
$130.7B
Net Income (TTM)
$85.8B
Operating Margin
32.6%
Profit Margin
22.3%
ROE
12.1%
ROA
6.0%
Total Assets (Q2 2026)
$1,263.1B
Total Equity (Q2 2026)
$747.9B
Cash & Cash Equivalents (Q2 2026)
$40.6B
Short-term Investments (Q2 2026)
$324.9B
Cash + ST Investments (Q2 2026)
$365.5B
Long-Term Debt (Q2 2026)
$125.9B
Total Debt (Q2 2026)
$128.6B
Net Debt (Q2 2026)
$87.99B
Current Ratio (Q2 2026)
2.89
Operating Cash Flow (Q2 2026)
$11.22B
Free Cash Flow (Q2 2026)
$5.57B
CapEx (Q2 2026)
$5.65B
Stock Repurchases (Q2 2026)
$4.21B
Buybacks YTD 2026
$4.4B
Q2 2026 Revenue
$117.9B
Q2 2026 Pretax Income
$32.06B
Q2 2026 Net Income
$25.67B
Q2 2026 Diluted EPS
$11.91
Tax Rate (Q2 2026)
19.6%
Goodwill (Q2 2026)
$83.2B
Net PPE (Q2 2026)
$244.1B
Retained Earnings (Q2 2026)
$799.0B
Treasury Stock (Q2 2026)
$83.7B
Insurance Float
Not specified
Equity Portfolio / Investments
~$685B
Strengths
Concerns
Berkshire Hathaway is a mega-cap diversified conglomerate (~$1.1T market cap) with fortress-level balance sheet strength, generating ~$10-11B in stable quarterly operating cash flow from its insurance, rail, and energy operations. The TTM P/E of 12.99x appears attractive, but the forward P/E of 23.65x signals significant earnings normalization expected by analysts from current elevated levels driven by investment portfolio mark-to-market gains. The recent resumption of buybacks ($4.2B in Q2 2026) represents a historically meaningful bullish signal from management, while the $365.5B cash hoard provides substantial optionality for acquisitions or continued share repurchases — the most underappreciated source of potential upside.
Macro: Polymarket data (Aug 11) shows 86% probability of zero Fed rate cuts in 2026, with 8% recession odds by year-end. July CPI print due Aug 12 with 72% probability of ≥0.1% MoM increase and YoY likely at 3.3–3.4%. Oil bid on US-Iran deal doubts; geopolitical uncertainty elevated. Market internals mixed with U.S. small caps lagging and growth sectors pressured ahead of CPI.